Under construction – not a live service
Sign in
Taking people in GermanyNo phase

Screens children for early type 1 diabetes during routine check-ups

Screens children aged 2 to 10 for early signs of type 1 diabetes.

Plain-language title generated from the registry record
Registry title: Fr1da Early Diagnosis and Care of Type 1 Diabetes

Key facts

Where
Munich, GermanySee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 2 and 10 years old?

Source: NCT04039945, who can take part

Where in Germany

  • Institut für Diabetesforschung, Helmholtz Zentrum MünchenMunich, GermanyTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Helmholtz Zentrum München
Trial code
NCT04039945
Record updated
17 December 2024
Original description
The Fr1da study: "Early diagnosis and care of type 1 diabetes" aims to carry out a comprehensive, population-based screening for the early diagnosis of type 1 diabetes as part of the U7 to U11 preventive medical check-up for children or between the ages of 2 and 10 years in Bavaria and to implement it in other federal states. Screening is recommended at two time points: 1st screening at the age of 3 years (U7a) and 2nd screening at the age of 7 years (U10). In addition, relatives of patients with type 1 diabetes between the ages of 1 and 21 can be screened repeatedly at intervals of 3 to 5 years for an early-stage of type 1 diabetes.Read full original descriptionShow less

Fr1da Early Diagnosis and Care of Type 1 Diabetes

The Fr1da study: "Early diagnosis and care of type 1 diabetes" aims to carry out a comprehensive, population-based screening for the early diagnosis of type 1 diabetes as part of the U7 to U11 preventive medical check-up for children or between the ages of 2 and 10 years in Bavaria and to implement it in other federal states. Screening is recommended at two time points: 1st screening at the age of 3 years (U7a) and 2nd screening at the age of 7 years (U10). In addition, relatives of patients with type 1 diabetes between the ages of 1 and 21 can be screened repeatedly at intervals of 3 to 5 years for an early-stage of type 1 diabetes.

written informed consent by one custodial parent.

ClinicalTrials.gov NCT04039945